CONTEXT: No formal comparison has been made between the pediatric post–highly active
antiretroviral therapy (HAART) outcomes of resource-limited and developed countries …

Objective With increasing maternal antiretroviral treatment (ART), the number of children
newly infected with HIV has declined. However, the possible increased mortality in the large …

Objectives: To evaluate severe (grade 3/4) morbidity and mortality in HIV-exposed,
uninfected infants. Design: Secondary data analysis of The Breastfeeding, Antiretrovirals …

Background: Up to 30% of infants may be HIV-exposed noninfected (ENI) in countries with
high HIV prevalence, but the impact of maternal HIV on the child's health remains unclear …

Background: HIV-exposed uninfected (HEU) infants are a growing population with
potentially poor health outcomes. We evaluated morbidity and mortality in HEU formula-fed …

Background Human immunodeficiency virus (HIV)–infected pregnant women increasingly
receive antiretroviral therapy (ART) to prevent mother-to-child transmission (PMTCT) …

Objective To compare health and growth outcomes in children infected with HIV, children
exposed to but uninfected with HIV, and children unexposed to HIV. Study design Our cohort …

Objective: HIV-exposed uninfected (HEU) infants have higher infectious disease morbidity
and mortality than unexposed infants. We determined the incidence and risk factors for …

Objective To evaluate growth parameters assessed by weight and length in HIV‐infected
and HIV‐uninfected infants born to HIV‐infected mothers in South Africa from birth to 6 …

Background HIV-infected and HIV-exposed, uninfected infants experience a high burden of
infectious morbidity and mortality. Hospitalization is an important metric for morbidity and is …